Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2016 1
2019 2
2020 8
2021 8
2022 3
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Results by year

Filters applied: . Clear all
Page 1
The Rheumatology Drugs for COVID-19 Management: Which and When?
Atzeni F, Masala IF, Rodríguez-Carrio J, Ríos-Garcés R, Gerratana E, La Corte L, Giallanza M, Nucera V, Riva A, Espinosa G, Cervera R. Atzeni F, et al. Among authors: rios garces r. J Clin Med. 2021 Feb 16;10(4):783. doi: 10.3390/jcm10040783. J Clin Med. 2021. PMID: 33669218 Free PMC article. Review.
Treat-to-target in systemic lupus erythematosus: Where are we?
Ríos-Garcés R, Espinosa G, van Vollenhoven R, Cervera R. Ríos-Garcés R, et al. Eur J Intern Med. 2020 Apr;74:29-34. doi: 10.1016/j.ejim.2020.01.018. Epub 2020 Feb 1. Eur J Intern Med. 2020. PMID: 32014364 Review.
Treatment for refractory lupus nephritis: Rituximab vs triple target therapy.
Cervera R, Mosca M, Ríos-Garcés R, Espinosa G, Trujillo H, Bada T, Praga M. Cervera R, et al. Among authors: rios garces r. Autoimmun Rev. 2019 Dec;18(12):102406. doi: 10.1016/j.autrev.2019.102406. Epub 2019 Oct 22. Autoimmun Rev. 2019. PMID: 31654743 Review. No abstract available.
Blocking GM-CSF receptor α with mavrilimumab reduces infiltrating cells, pro-inflammatory markers and neoangiogenesis in ex vivo cultured arteries from patients with giant cell arteritis.
Corbera-Bellalta M, Alba-Rovira R, Muralidharan S, Espígol-Frigolé G, Ríos-Garcés R, Marco-Hernández J, Denuc A, Kamberovic F, Pérez-Galán P, Joseph A, D'Andrea A, Bondensgaard K, Cid MC, Paolini JF. Corbera-Bellalta M, et al. Among authors: rios garces r. Ann Rheum Dis. 2022 Apr;81(4):524-536. doi: 10.1136/annrheumdis-2021-220873. Epub 2022 Jan 19. Ann Rheum Dis. 2022. PMID: 35045965 Free PMC article.
Anti-Neutrophil Extracellular Trap Antibodies in Antiphospholipid Antibody-Positive Patients: Results From the Antiphospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking Clinical Database and Repository.
Zuo Y, Navaz S, Tsodikov A, Kmetova K, Kluge L, Ambati A, Hoy CK, Yalavarthi S, de Andrade D, Tektonidou MG, Sciascia S, Pengo V, Ruiz-Irastorza G, Belmont HM, Gerosa M, Fortin PR, de Jesus GR, Branch DW, Andreoli L, Rodriguez-Almaraz E, Petri M, Cervera R, Willis R, Karp DR, Li QZ, Cohen H, Bertolaccini ML, Erkan D, Knight JS; Antiphospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking. Zuo Y, et al. Arthritis Rheumatol. 2023 Aug;75(8):1407-1414. doi: 10.1002/art.42489. Epub 2023 May 18. Arthritis Rheumatol. 2023. PMID: 36862141 Free article.
Significance of clinical-immunological patterns and diagnostic yield of biopsies in microscopic polyangiitis and granulomatosis with polyangiitis.
Fernandes-Serodio J, Prieto-González S, Espígol-Frigolé G, Ríos-Garcés R, Gómez-Caverzaschi V, Araújo O, Espinosa G, Jordà-Sánchez R, Alba MA, Quintana L, Blasco M, Guillen E, Viñas O, Ruiz-Ortiz E, Pelegrín L, Sainz de la Maza M, Sánchez-Dalmau B, García-Herrera A, Solé M, Castillo P, Aldecoa I, Cano MD, Sellarés J, Hernández-González F, Agustí C, Lucena CM, López-Rueda A, Sánchez M, Benegas M, Capurro S, Sanmartí R, Grau JM, Vilaseca I, Alobid I, Cid MC, Hernández-Rodríguez J. Fernandes-Serodio J, et al. Among authors: rios garces r. J Intern Med. 2024 May;295(5):651-667. doi: 10.1111/joim.13777. Epub 2024 Mar 11. J Intern Med. 2024. PMID: 38462959
Fluctuation of Anti-Domain 1 and Anti-β2 -Glycoprotein I Antibody Titers Over Time in Patients With Persistently Positive Antiphospholipid Antibodies.
Chighizola CB, Pregnolato F, Andrade D, Tektonidou M, Pengo V, Ruiz-Irastorza G, Belmont HM, Gerosa M, Fortin P, Branch DW, Andreoli L, Petri MA, Cervera R, Knight JS, Willis R, Efthymiou M, Cohen H, Erkan D, Bertolaccini ML; Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION). Chighizola CB, et al. Arthritis Rheumatol. 2023 Jun;75(6):984-995. doi: 10.1002/art.42459. Epub 2023 Apr 2. Arthritis Rheumatol. 2023. PMID: 36704930 Free article.
26 results